Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Covalent coupling of high-affinity ligands to the surface of viral vector particles by protein trans-splicing mediates cell type-specific gene transfer.

Muik A, Reul J, Friedel T, Muth A, Hartmann KP, Schneider IC, Münch RC, Buchholz CJ.

Biomaterials. 2017 Nov;144:84-94. doi: 10.1016/j.biomaterials.2017.07.032. Epub 2017 Jul 25.

PMID:
28825979
2.

Ligand Coupling to the AAV Capsid for Cell-Specific Gene Transfer.

Reul J, Muik A, Buchholz CJ.

Methods Mol Biol. 2019;1950:35-50. doi: 10.1007/978-1-4939-9139-6_3.

PMID:
30783967
4.

Displaying high-affinity ligands on adeno-associated viral vectors enables tumor cell-specific and safe gene transfer.

Münch RC, Janicki H, Völker I, Rasbach A, Hallek M, Büning H, Buchholz CJ.

Mol Ther. 2013 Jan;21(1):109-18. doi: 10.1038/mt.2012.186. Epub 2012 Sep 11.

5.

Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus.

Warrington KH Jr, Gorbatyuk OS, Harrison JK, Opie SR, Zolotukhin S, Muzyczka N.

J Virol. 2004 Jun;78(12):6595-609.

6.

Off-target-free gene delivery by affinity-purified receptor-targeted viral vectors.

Münch RC, Muth A, Muik A, Friedel T, Schmatz J, Dreier B, Trkola A, Plückthun A, Büning H, Buchholz CJ.

Nat Commun. 2015 Feb 10;6:6246. doi: 10.1038/ncomms7246.

PMID:
25665714
7.

Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.

Hirsch ML, Wolf SJ, Samulski RJ.

Methods Mol Biol. 2016;1382:21-39. doi: 10.1007/978-1-4939-3271-9_2.

8.

Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups.

Rabinowitz JE, Bowles DE, Faust SM, Ledford JG, Cunningham SE, Samulski RJ.

J Virol. 2004 May;78(9):4421-32.

9.

Widespread Central Nervous System Gene Transfer and Silencing After Systemic Delivery of Novel AAV-AS Vector.

Choudhury SR, Harris AF, Cabral DJ, Keeler AM, Sapp E, Ferreira JS, Gray-Edwards HL, Johnson JA, Johnson AK, Su Q, Stoica L, DiFiglia M, Aronin N, Martin DR, Gao G, Sena-Esteves M.

Mol Ther. 2016 Apr;24(4):726-35. doi: 10.1038/mt.2015.231. Epub 2015 Dec 28.

10.

Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors.

Kay CN, Ryals RC, Aslanidi GV, Min SH, Ruan Q, Sun J, Dyka FM, Kasuga D, Ayala AE, Van Vliet K, Agbandje-McKenna M, Hauswirth WW, Boye SL, Boye SE.

PLoS One. 2013 Apr 26;8(4):e62097. doi: 10.1371/journal.pone.0062097. Print 2013. Erratum in: PLoS One. 2013;8(9). doi:10.1371/annotation/99ee1789-a658-4fb0-8593-40a40e9f344a.

11.

[Post-translational ligation and function of dual-vector transferred split CFTR gene].

Zhu FX, Liu ZL, Qu HG, Chi XY.

Yao Xue Xue Bao. 2010 Jan;45(1):60-5. Chinese.

PMID:
21351451
13.

Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice.

Koo T, Popplewell L, Athanasopoulos T, Dickson G.

Hum Gene Ther. 2014 Feb;25(2):98-108. doi: 10.1089/hum.2013.164. Epub 2013 Dec 19.

PMID:
24191945
14.

Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands.

Ponnazhagan S, Mahendra G, Kumar S, Thompson JA, Castillas M Jr.

J Virol. 2002 Dec;76(24):12900-7.

15.

Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.

Müller OJ, Leuchs B, Pleger ST, Grimm D, Franz WM, Katus HA, Kleinschmidt JA.

Cardiovasc Res. 2006 Apr 1;70(1):70-8. Epub 2006 Jan 31.

PMID:
16448634
16.

Impact of capsid modifications by selected peptide ligands on recombinant adeno-associated virus serotype 2-mediated gene transduction.

Naumer M, Popa-Wagner R, Kleinschmidt JA.

J Gen Virol. 2012 Oct;93(Pt 10):2131-41. doi: 10.1099/vir.0.044735-0. Epub 2012 Jul 4.

PMID:
22764318
17.
18.

Relevance of Assembly-Activating Protein for Adeno-associated Virus Vector Production and Capsid Protein Stability in Mammalian and Insect Cells.

Grosse S, Penaud-Budloo M, Herrmann AK, Börner K, Fakhiri J, Laketa V, Krämer C, Wiedtke E, Gunkel M, Ménard L, Ayuso E, Grimm D.

J Virol. 2017 Sep 27;91(20). pii: e01198-17. doi: 10.1128/JVI.01198-17. Print 2017 Oct 15.

19.

Oversized AAV transductifon is mediated via a DNA-PKcs-independent, Rad51C-dependent repair pathway.

Hirsch ML, Li C, Bellon I, Yin C, Chavala S, Pryadkina M, Richard I, Samulski RJ.

Mol Ther. 2013 Dec;21(12):2205-16. doi: 10.1038/mt.2013.184. Epub 2013 Aug 13.

Supplemental Content

Support Center